The Myeloma Patient Outcome Scale is the first quality of life tool developed for clinical use and validated in patients with follicular lymphoma

OBJECTIVES: The development of novel agents and an ageing population has led to an increasing number of patients with follicular lymphoma (FL) living longer with their disease. Health‐related quality of life (HRQOL) is a priority for patients and should guide clinical decisions. The Myeloma Patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Davies, Joanna M., Osborne, Thomas R., Edmonds, Polly M., Schey, Steve A., Devereux, Steve, Higginson, Irene J., Ramsenthaler, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413861/
https://www.ncbi.nlm.nih.gov/pubmed/28160316
http://dx.doi.org/10.1111/ejh.12864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413861/
https://www.ncbi.nlm.nih.gov/pubmed/28160316
http://dx.doi.org/10.1111/ejh.12864

Ejemplares similares